MedTrace Logo

Study of Attention and Memory Treatments for Cancer Survivors

NCT04870320 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2022-04-08

No results posted yet for this study

Summary

This clinical trial investigates if certain electronic games may be effective in improving attention and memory function in cancer survivors. Cancer related cognitive impairment (CRCI) is an issue experienced by many cancer patients/survivors. CRCI includes perceived or objective problems with memory, executive function, and attention/concentration. CRCI has a negative impact on survivors' ability to work, carry out routine activities, and engage in social and family relationships. CRCI may result in significant distress and reduced quality of life. Certain electronic games may help improve attention and memory function in cancer survivors and reduce symptoms of CRCI.

Conditions

  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm

Interventions

BEHAVIORAL

Endeavor: Computer-Based Cognitive Stimulation Intervention

Endeavor application will be utilized by participant on iPad

BEHAVIORAL

Words!: Computer-Based Cognitive Stimulation Intervention

Words! application will be utilized by participant on iPad

OTHER

Quality of Life (QOL) Questionnaires

Standardized QOL questionnaire will be administered at each study visit

Sponsors & Collaborators

Principal Investigators

  • Christine Miaskowski, RN, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04870320 on ClinicalTrials.gov